August 2025 in “Veterinary Dermatology” This study examined 14 dogs with alopecia areata and found that oral ciclosporin was the most common treatment, with some dogs experiencing hair regrowth, though relapses were common when the medication was tapered or withdrawn.
August 2025 in “Biomolecules” This review discusses the potential topical benefits of cannabidiol in dermatology and cosmetics, highlighting its diverse effects and therapeutic roles but reports no new clinical results, emphasizing the need for further research.
July 2025 in “Journal of Investigative Dermatology” Candida auris uses the immune response to colonize hair follicles.
July 2025 in “Current Treatment Options in Oncology” This opinion piece discusses strategies for managing cancer-related alopecia, emphasizing personalized approaches including scalp cooling and topical minoxidil, but it reports no new clinical results.
July 2025 in “Canadian Family Physician” This source summarizes the new 2024 American Academy of Dermatology guidelines, emphasizing strong recommendations for topical and oral therapies like benzoyl peroxide, doxycycline, and isotretinoin in managing acne vulgaris, while outlining the importance of tailored treatments for diverse patient needs in Canadian practice.
May 2025 in “International Journal of Trichology” In this case report, a 60-year-old man with rheumatoid arthritis and sudden hair whitening was treated with baricitinib, showing significant hair repigmentation and regrowth in 8 months, suggesting potential for baricitinib in managing canities subita, especially when linked to alopecia areata.
This systematic review reported that treatment with drugs that activate the Wnt pathway, including valproic acid and lithium, was not associated with a significant increase in cancer risk. The authors suggest further research on Wnt activation's potential as a regenerative therapy.
April 2025 in “Frontiers in Pharmacology” This study found that targeting RARβ and RXRA with CANA, in combination with MPA, could help overcome progestin resistance by restoring BAX levels and downregulating CRABP2, suggesting a novel strategy for improving clinical efficacy in this context.
April 2025 in “Cancer Research” This study examined older adults undergoing chemotherapy and found that nutritional-inflammatory biomarker ratios were significantly linked to cognitive impairments, treatment side effects, and quality of life indicators, suggesting these lab measurements might help identify high-risk individuals for intervention.
March 2025 in “PHARMADEMICA Jurnal Kefarmasian dan Gizi” This study evaluated cucumber extract shampoos and found they meet physical quality standards and exhibit strong antifungal activity against Candida albicans fungi, with efficacy increasing with higher concentrations of cucumber extract.
March 2025 in “Journal of Dermatological Treatment” In this case report, a patient required more local anesthetic than usual for hair transplant surgery, which the authors suggest may be due to cannabis use impacting pain sensitivity and anesthetic clearance.
March 2025 in “Canadian dermatology today.” In this case series, treatment with clascoterone cream 1% was reported to be effective and well tolerated for diverse acne vulgaris patients, improving clinical outcomes whether used alone or in combination with other therapies, and addressing various other skin conditions.
March 2025 in “Journal of Investigative Dermatology” In this survey study, 44% of epidermolysis bullosa patients who tried cannabinoids reported effective symptom management, particularly pain relief, but concerns about cost, stigma, and accessibility remain significant. Further research is necessary to confirm these findings and optimize cannabinoid therapies for EB.
February 2025 in “Processes” This study highlights the potential of chitosan nanoparticles to improve cannabidiol solubility and delivery for treating alopecia, suggesting a promising approach for transdermal delivery of hydrophobic compounds.
February 2025 in “International Journal For Multidisciplinary Research” In this descriptive study conducted in a tertiary care center in Chennai, researchers observed that chemotherapy-induced hair loss seriously impacts the emotional well-being of cancer survivors, especially women and younger individuals, with severity of hair loss correlating strongly with psychological distress.
January 2025 in “Journal of Materials Chemistry B” This abstract discusses androgenetic alopecia treatments like oral finasteride and topical minoxidil, reporting limited treatment efficacy and no new findings, and emphasizes the psychological impact on patients.
January 2025 in “International Journal of Advanced Biochemistry Research” In this study, dogs diagnosed with demodicosis achieved full recovery after a single dose of fluralaner, with clinical improvement supported by negative skin scraping results by day 28, and hematobiochemical parameters normalizing over the treatment period.
October 2024 in “Aesthetic Cosmetology and Medicine” This study examined the potential benefits of incorporating cannabis-derived compounds like cannabidiol and seed oil into skincare products, finding they may improve skin health and address inflammation and dermatological issues, thus supporting their role in developing effective cosmeceuticals.
August 2024 in “Proceeding Cendekia International Conference Health and Technology” In this quasi-experimental study, researchers explored the optimal formulation of a nanoemulsion containing candlenut ethanol extract, finding that specific combinations of tween 80, span 80, and sonication time affected its physical properties and stability, although further activity testing is needed.
June 2024 in “Pharmacon Jurnal Farmasi Indonesia” In this study, researchers evaluated different formulations of a nanoemulsion combining candlenut oil and virgin coconut oil on male rats and found that a 1:3 ratio yielded significant hair growth results, with an average hair length of 17.14 mm and a weight of 699.37 mg.
June 2024 in “British Journal of Dermatology” This narrative focuses on the experiences of two women with permanent chemotherapy-induced alopecia, highlighting the severe psychological and social impact along with dissatisfaction over pre-treatment information about hair loss, which they initially believed to be temporary.
June 2024 in “Journal of Clinical Oncology” In this study, researchers analyzed data showing that Black women became the racial group with the highest incidence of endometrial cancer starting in 2017, associating frequent use of chemical hair relaxers with an increased risk of this cancer.
June 2024 in “Lontara Journal Of Health Science And Technology” This study evaluated the effects of candlenut oil, olive oil, and their combination on hair growth in male rabbits, finding that candlenut oil led to the greatest hair length increase compared to olive oil or the combination, which also showed significant effects.
May 2024 in “Microbial Biosystems Journal” This study found that the antifungal potential of six herbal shampoos developed using various phytoconstituents is comparable to marketed synthetic antifungal shampoos in treating Seborrheic dermatitis caused by Candida albicans.
March 2024 in “Brazilian Journal of Veterinary Pathology” This case report reviews the clinical presentation and diagnostic evaluations of a Samoyed dog with non-pruritic alopecia, but no new results were reported.
March 2024 in “Cancer Research” This meta-analysis found that men with vertex balding at age 40 or older may have a modestly increased risk of prostate cancer, with a pooled relative risk of 1.08, but no significant association was observed with frontal balding.
February 2024 in “Jurnal Kesehatan Yamasi Makassar” This study in South Sulawesi Province developed a shampoo using ethanol extract from Pondoh salak fruit peel, which met physical stability tests and demonstrated strong inhibitory effects against Staphylococcus epidermidis and Candida albicans, with formulations ranging from 10% to 20% concentrations.
February 2024 in “Cancers” This review highlights recent progress in developing androgen receptor degraders, such as PROTACs, for treating castration-resistant prostate cancer, and notes that several have entered phase I or II clinical trials, showcasing potential to address drug resistance challenges.
January 2024 in “Brazilian journal of veterinary pathology” In this case report, a 6-year-old spayed female Samoyed dog presented with non-pruritic alopecia and hyperpigmentation on the hips and back, with unremarkable bloodwork and negative Cushing's disease and skin tests.
January 2024 in “International journal of advanced biochemistry research” This case study reported that a one-year-old male dog with demodicosis successfully recovered after treatment with Bravecto (fluralaner) and supportive therapies, highlighting the importance of recognizing and managing Demodex canis infections in dogs.